close
MENU
Hot Topic Hawke’s Bay
How to guide
How to guide
Home
The NBR List
NBR View
NBR Marketplace

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

Podcasts Audio Articles Entrepreneurs Your Business Beehive Banter Morning Brew Toil & Trouble NZ Aviation News Back Issues Market Outlook Dollars & Sense Private Bin Opinion (Archive) NBR Radar (Archive) NBR Rich List (Archive)
Hot Topic Hawke’s Bay
General Business
4 mins to read
1

Over $15m invested in AK University biotech startup

TamoRx aims to develop world-leading cancer immunotherapy.

Dr Joanna Mathy along with Professor Rod Dunbar are behind the novel discovery.

Fiona Rotherham Wed, 25 May 2022

Biotech startup TamoRx has received $15.25 million in investment to speed up development of a new cancer treatment.

The startup, spun out recently from the University of Auckland, was founded by Dr Joanna Mathy and Professor Rod Dunbar from the university’s school of Biological Sciences.

It is

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
View terms and conditions.
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Fiona Rotherham Wed, 25 May 2022
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Tags
TamoRx Dr Joanna Mathy Professor Rod Dunbar Brandon Capital
Related News
General Business
2

Brandon Capital leads $14m investment to develop new cancer drug
Investment
1

Deep tech incubators make long-delayed first investments
General Business

Pioneering drug developer wins top award
Related News
General Business
2

Brandon Capital leads $14m investment to develop new cancer drug
Investment
1

Deep tech incubators make long-delayed first investments
General Business

Pioneering drug developer wins top award
Over $15m invested in AK University biotech startup
General Business,
94177
true
Subscribe Login